The HDAC inhibitor SB939 overcomes resistance to BCR-ABL kinase Inhibitors conferred by the BIM deletion polymorphism in chronic myeloid leukemia

por Rauzan, Muhammad, Chuah, Charles T. H., Ko, Tun Kiat, Ong, S. Tiong
Publicado 2017

High-throughput genotyping of CRISPR/Cas9-mediated mutants using fluorescent PCR-capillary gel electrophoresis

por Ramlee, Muhammad Khairul, Yan, Tingdong, Cheung, Alice M. S., Chuah, Charles T. H., Li, Shang
Publicado 2015

The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

por Ko, Tun Kiat, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Ong, S. Tiong
Publicado 2014

The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia

por Ko, Tun Kiat, Chin, Hui San, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Khaw, Seong Lin, Huang, David C.S., Ong, S. Tiong
Publicado 2015

A novel Bcr-Abl–mTOR–eIF4A axis regulates IRES-mediated translation of LEF-1

por Tsai, Becky Pinjou, Jimenez, Judith, Lim, Sharon, Fitzgerald, Kerry D., Zhang, Min, Chuah, Charles T. H., Axelrod, Haley, Nelson, Luke, Ong, S. Tiong, Semler, Bert L., Waterman, Marian L.
Publicado 2014